FDA Approves Tx for Rare Genetic Disorder PH1 – Oxlumo
Ok, catch up time.Looking back a couple of weeks….. the FDA approved yet another rare/orphan therapy (which is mostly all they they’ve approved in 2020!).
December 8, 2020
Ok, catch up time.Looking back a couple of weeks….. the FDA approved yet another rare/orphan therapy (which is mostly all they they’ve approved in 2020!).
With the emergence of CV-19 just about every health care provider has been scrambling to do something to preserve their patient relationships. A patient that
The FDA recently revved up its approval engine waving yet another specialty pharmacy checkered flag for Zokinvy (lonafarnib) from Eiger BioPharmaceuticals. Zokinvy is indicated for
For a while we were seeing FDA specialty drugs approvals on a fairly regular basis….. then crickets. Perhaps the hiatus is over with the approval
Once in a while it is good to believe in facts.The brief article below deserves some serious attention as it includes some really positive facts
Specialty pharmacy under Medicaid is a bellwether for making observations on the broader specialty market and where the market is headed. Since Medicaid is state
I’ve been ringing the alarm bell for several years now alerting the specialty pharmacy industry that it was under attack by health system owned specialty
There are almost always one or a few people within a specialty pharmacy that can wax on at length over the topic of compliance. Compliance
OK, this is not fake news….. the press release below details a new, exclusive-distribution arrangement for an oral therapy, Lysodren, with an indication for inoperable,
We’ve often admonished people working in specialty pharmacy to be in the forefront of new developments. That’s easier said than done especially since the low
